These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 6192747

  • 1. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin].
    Laccourreye H, Beutter P, Brasnu D, Lacau-Saint-Guily J, Bassot V, Garabedian N, Jacquillat C.
    Ann Otolaryngol Chir Cervicofac; 1983; 100(4):269-74. PubMed ID: 6192747
    [Abstract] [Full Text] [Related]

  • 2. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
    Mika H.
    Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
    [Abstract] [Full Text] [Related]

  • 3. [Randomized trial of initial chemotherapy with cisplatin alone or in combination in 241 advanced carcinomas of the upper respiratory and digestive tract].
    Chauvergne J, Cappelaere P, Clavel B, David M, Fargeot P, Meeus L, Traissac L, Klein T.
    Ann Otolaryngol Chir Cervicofac; 1988 Sep; 105(8):581-9. PubMed ID: 2470310
    [Abstract] [Full Text] [Related]

  • 4. [Induction chemotherapy in cancer of the upper respiratory and digestive tract. Preliminary results of the protocol combining cisplatin, 5-fluorouracil and bleomycin (CFB)].
    Laccourreye H, Bassot V, Lacau St Guily J, Brasnu D, Menard M, Donnadieu S, Jacquillat C.
    Ann Otolaryngol Chir Cervicofac; 1985 Sep; 102(1):1-6. PubMed ID: 2408533
    [Abstract] [Full Text] [Related]

  • 5. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
    Deitmer T, Urbanitz D.
    Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of epidermoid carcinoma of the oro-pharyngo-laryngeal area with combination of methotrexate and bleomycin].
    Broquet MA, Jacot-Descombe E, Montandon A, Alberto P.
    Schweiz Med Wochenschr; 1974 Jan 05; 104(1):18-22. PubMed ID: 4128917
    [No Abstract] [Full Text] [Related]

  • 7. [Tumor and lymph node response to chemotherapy. Prognosis in cancer of the pyriform sinus and the lateral laryngeal margin].
    Janot F, Laccourreye H, Bassot V, Brasnu D, Ménard M, Fabre A.
    Ann Otolaryngol Chir Cervicofac; 1988 Jan 05; 105(6):415-21. PubMed ID: 2462399
    [Abstract] [Full Text] [Related]

  • 8. [Induction chemotherapy of carcinomas of the oral cavity and oropharynx. Feasibility study, levels and factors of response to treatment. Apropos of 135 cases].
    Calais G, Goga D, Le Flock O, Ballon G.
    Rev Stomatol Chir Maxillofac; 1987 Jan 05; 88(5):359-64. PubMed ID: 2448863
    [Abstract] [Full Text] [Related]

  • 9. [Preliminary results of a preoperative polychemotherapy protocol in carcinomas of the pharyngo-larynx. Oncovin, methotrexate and bleomycin (author's transl)].
    Laccourreye H, Brasnu D, Beutter P, Chabolle F, de Braquilanges E, Strunski W.
    Ann Otolaryngol Chir Cervicofac; 1981 Jan 05; 98(9):411-24. PubMed ID: 6176169
    [Abstract] [Full Text] [Related]

  • 10. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
    Campbell JB, Dorman EB, McCormick M, Miles J, Morton RP, Rugman F, Stell PM, Stoney PJ, Vaughan ED, Wilson JA.
    Acta Otolaryngol; 1987 Jan 05; 103(5-6):519-28. PubMed ID: 3303823
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J.
    J Urol; 1998 Nov 05; 160(5):1770-4. PubMed ID: 9783949
    [Abstract] [Full Text] [Related]

  • 12. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C, Odell P, Danjoux C, Nichol J, de la Bastide Y, Barron P, Hardie J.
    J Otolaryngol; 1985 Dec 05; 14(6):391-3. PubMed ID: 2416947
    [Abstract] [Full Text] [Related]

  • 13. [Pathohistologic studies of serial sections of squamous cell cancer of the oral cavity and oropharynx following cytostatic induction therapy with bleomycin and cisplatin].
    Bettinger R, Meyer-Breiting E, Klima A.
    Laryngol Rhinol Otol (Stuttg); 1988 Nov 05; 67(11):580-5. PubMed ID: 2467153
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A, Cummings G, Al-Sarraf M.
    Cancer; 1983 Aug 01; 52(3):399-403. PubMed ID: 6190548
    [Abstract] [Full Text] [Related]

  • 15. [Adjuvant chemotherapy in supraglottic epidermoid carcinoma stage T3].
    Brasnu D, Laccourreye O, Chabardes E, Charial JP, Huart J, Bassot V, Laccourreye H.
    Ann Otolaryngol Chir Cervicofac; 1992 Aug 01; 109(6):286-8. PubMed ID: 1298174
    [Abstract] [Full Text] [Related]

  • 16. Failure of alkylating agents to improve induction chemotherapy of oropharyngeal squamous cell cancer.
    Olasz L, Nyárády Z, Németh A, Királyfalvi L, Ember I.
    Anticancer Res; 2004 Aug 01; 24(4):2557-61. PubMed ID: 15330214
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 01; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 18. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA, MacRae K, Hill BT.
    Cancer Treat Rep; 1983 Jun 01; 67(6):535-9. PubMed ID: 6190557
    [Abstract] [Full Text] [Related]

  • 19. [Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].
    Bienengräber V.
    Arch Geschwulstforsch; 1986 Jun 01; 56(5):353-6. PubMed ID: 2429630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.